Sorce Lauren R, Hamilton Susan M, Gauvreau Kimberlee, Mets Marilyn B, Hunter David G, Rahmani Bahram, Wu Carolyn, Curley Martha A Q
Children's Memorial Hospital, Chicago, IL, USA.
Pediatr Crit Care Med. 2009 Mar;10(2):171-5. doi: 10.1097/PCC.0b013e3181956ccf.
To determine the incidence of corneal abrasions in critically ill children requiring neuromuscular blockade (NMB) and to determine whether a moisture chamber over the eye is more effective in preventing corneal abrasions compared with standard therapy.
Randomized controlled clinical trial.
Three pediatric intensive care units at two free-standing, university-affiliated children's hospitals.
Consecutive intubated, mechanically ventilated patients receiving NMB <36 hours, 2 weeks to 18 years of age.
After confirming the absence of a corneal abrasion, patients' eyes were randomized to either control (Q6H lubrication and eye closure) or treatment (Q6H lubrication, eyelid closure and moisture chamber). Eyes were examined daily for 3 days then every other day until NMB was discontinued, a corneal abrasion developed, or on study day 9. Data were analyzed on an intention-to-treat basis.
Two hundred thirty-seven patients were enrolled. Thirty patients exited the study before randomization (17 upon confirmation of a corneal abrasion on initial examination [7%; 95% confidence interval 4%-11%]; 12 upon discontinuation of NMB; 1 patient death). The remaining 207 patients were randomized and evaluated twice (median; interquartile range [IQR] 1-4 observations). Twenty-one patients developed a corneal abrasion over the course of the study (10%; 95%confidence interval 6%-15%). Median time from enrollment to abrasion was 2 days (IQR 1-3 days). The incidence of corneal abrasion was not different between the patient's control and treatment eyes; specifically, eight corneal abrasions developed in the control eye, five corneal abrasions in the treatment eye, and eight corneal abrasions in both eyes (McNemar's test; p = 0.58).
The occurrence of corneal abrasions in critically ill children receiving NMB is not trivial. The additional use of a moisture chamber over the eye was no more effective than Q6H lubrication and eye closure alone in preventing corneal abrasions in this at-risk patient group.
确定需要接受神经肌肉阻滞剂(NMB)治疗的重症患儿角膜擦伤的发生率,并确定与标准治疗相比,眼部使用保湿眼罩在预防角膜擦伤方面是否更有效。
随机对照临床试验。
两家独立的、与大学相关的儿童医院的三个儿科重症监护病房。
连续入选的年龄在2周龄至18岁之间、接受NMB治疗时间小于36小时且正在接受气管插管和机械通气的患者。
在确认无角膜擦伤后,将患者的眼睛随机分为对照组(每6小时润滑和闭合眼睑)或治疗组(每6小时润滑、闭合眼睑并使用保湿眼罩)。每天检查眼睛,持续3天,然后每隔一天检查一次,直至停用NMB、出现角膜擦伤或到研究第9天。按意向性分析原则进行数据分析。
共纳入237例患者。30例患者在随机分组前退出研究(17例在初次检查时确诊有角膜擦伤[7%;95%置信区间4%-11%];12例在停用NMB后退出;1例死亡)。其余207例患者被随机分组并接受两次评估(中位数;四分位间距[IQR]为1-4次观察)。在研究过程中,21例患者出现角膜擦伤(10%;95%置信区间6%-15%)。从入组到出现擦伤的中位时间为2天(IQR为1-3天)。患者的对照眼和治疗眼的角膜擦伤发生率无差异;具体而言,对照眼出现8例角膜擦伤,治疗眼出现5例角膜擦伤,双眼均出现8例角膜擦伤(McNemar检验;p = 0.58)。
接受NMB治疗的重症患儿发生角膜擦伤并非少见。对于这个高危患者群体,在眼部额外使用保湿眼罩在预防角膜擦伤方面并不比单纯每6小时润滑和闭合眼睑更有效。